6: A phase 2 randomized, double-blind, placebo-controlled study to evaluate the effectiveness and safety of single, oral doses of SYM-1219, a granule formulation containing 1 and 2 gram doses of secnidazole, for the treatment of women with bacterial vaginosis

Journal article

Peer reviewed

S.L. Hillier, F.G. Morgan, A.S. Waldbaum, J.R. Schwebke, P. Nyirjesy, N. Adetoro and C.J. Braun

American journal of obstetrics and gynecology, v 213(6), pp 885-885

Dec 2015

Additional Links

3 Record Views

Title: 6: A phase 2 randomized, double-blind, placebo-controlled study to evaluate the effectiveness and safety of single, oral doses of SYM-1219, a granule formulation containing 1 and 2 gram doses of secnidazole, for the treatment of women with bacterial vaginosis
Creators: S.L. Hillier - University of Pittsburgh
F.G. Morgan - Clinical Research Associates of Tidewater
A.S. Waldbaum - Downtown Women's Health Care
J.R. Schwebke - University of Alabama at Birmingham
P. Nyirjesy - Drexel University
N. Adetoro - Product Innovation and Engineering (United States) (United States, Saint James) - LLC
C.J. Braun - Product Innovation and Engineering (United States) (United States, Saint James) - LLC
Publication Details: American journal of obstetrics and gynecology, v 213(6), pp 885-885
Publisher: Elsevier
Resource Type: Journal article
Language: English
Web of Science ID: WOS:000365764900048
Other Identifier: 991019350589504721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool: